The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis
Abstract
OBJECTIVE: This study assessed the efficacy of olanzapine in delaying or preventing conversion to psychosis and reducing symptoms in people with prodromal symptoms of schizophrenia. METHOD: This randomized trial occurred at four North American clinics in the Prevention Through Risk Identification, Management, and Education project. Outpatients received olanzapine (5-15 mg/day, N=31) or placebo (N=29) during a 1-year double-blind treatment period and no treatment during a 1-year follow-up period. Efficacy measures included the conversion-to-psychosis rate and Scale of Prodromal Symptoms scores. RESULTS: During the treatment year, 16.1% of olanzapine patients and 37.9% of placebo patients experienced a conversion to psychosis, a nearly significant difference. The hazard of conversion among placebo patients was about 2.5 times that among olanzapine-treated patients, which also approached significance. In the follow-up year, the conversion rate did not differ significantly between groups. During treatment, the mean score for prodromal positive symptoms improved more in the olanzapine group than in the placebo group, and the mixed-model repeated-measures least-squares mean score showed significantly greater improvement between weeks 8 and 28 with olanzapine. The olanzapine patients gained significantly more weight (mean=8.79 kg, SD=9.05, versus mean=0.30 kg, SD=4.24). CONCLUSIONS: A significant treatment difference in the conversion-to-psychosis rate was not demonstrated. However, these results may be influenced by low power. The nearly significant differences suggest that olanzapine might reduce the conversion rate and delay onset of psychosis. Olanzapine was efficacious for positive prodromal symptoms but induced weight gain. Further treatment research in this phase of illness is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, clinical trials have failed so far to provide clear evidence that antipsychotics can prevent conversion to schizophrenia in at-risk individuals 63 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
Simpson, G. M., B., M., B., G., Angus, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,265
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · The British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,179
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K. S., Ventura, J., McFarlane, W. R., Perkins, D. O., Pearlson, G. D., & Woods, S. W. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007040 · Cited by 1,800
Self-citationMeasurement of Premorbid Adjustment in Chronic Schizophrenia
Cannon-Spoor, H. E., Potkin, S. G., & Wyatt, R. J. (1982) · Schizophrenia Bulletin · doi:10.1093/schbul/8.3.470 · Cited by 1,220
Global Assessment of Functioning
Hall, R. C. W. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71666-8 · Cited by 1,099
McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- McGlashan TH, 2001, Netherlands, Kluwer Academic, 135
- Guy, 1976, ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338
Cited by
Sorted by citations
Items 301–400 of 557
Interventions for Youth at High Risk for Bipolar Disorder and Schizophrenia
McNamara, R. K., Strawn, J. R., Chang, K., & DelBello, M. P. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.009 · Cited by 16
Salokangas, R. K. R., Patterson, P. H., Heinimaa, M., Svirskis, T., From, T., Vaskelainen, L., Klosterkötter, J., Ruhrmann, S., von Reventlow, H. G., Juckel, G., et al. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.11.004 · Cited by 16
Moncrieff, J. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.085795 · Cited by 16
Higuchi, Y., Sumiyoshi, T., Tateno, T., Nakajima, S., Sasabayashi, D., Nishiyama, S., Mizukami, Y., Takahashi, T., & Suzuki, M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050327 · Cited by 16
Computerized Assessment of Psychosis Risk
Mittal, V. A., Ellman, L. M., Strauss, G. P., Walker, E. F., Corlett, P. R., Schiffman, J. E., Woods, S. W., Powers, A. R., Silverstein, S. M., Waltz, J. A., et al. (2021) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20210011 · Cited by 18
Self-citationCannabidiol for at risk for psychosis youth: A randomized controlled trial
Amminger, G. P., Lin, A. P., Kerr, M., Weller, A., Spark, J., Pugh, C., O’Callaghan, S., Berger, M., Clark, S. R., Scott, J. G., et al. (2021) · Early Intervention in Psychiatry · doi:10.1111/eip.13182 · Cited by 17
Prospective outcome of early intervention for individuals at ultra‐high‐risk for psychosis
Shim, G., Kang, D., Choi, J., Jung, M. H., Kwon, J. S., Jang, G.-E., & Kwon, J. S. (2008) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2008.00089.x · Cited by 15
Cognitive Behavioral Therapy in Prodromal Psychosis
Addington, J., Marshall, C., & French, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316082 · Cited by 16
Self-citationKao, Y., Wang, T., Lu, C.-W., Cheng, T.-H., & Liu, Y. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-011-0428-y · Cited by 16
Friedman‐Yakoobian, M. S., West, M. L., Woodberry, K. A., O’Donovan, K., Zimmet, S. V., Gnong-Granato, A., Giuliano, A. J., Guyer, M. E., Rodenhiser, J., Keshavan, M. S., et al. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000181 · Cited by 15
Early intervention in schizophrenia
Kulhara, P., Banerjee, A., & Dutt, A. (2008) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.42402 · Cited by 15
Metacognitive Therapy for Individuals at High Risk of Developing Psychosis: A Pilot Study
Parker, S., Mulligan, L. D., Milner, P., Bowe, S. E., & Palmier‐Claus, J. E. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.02741 · Cited by 14
Ethical Considerations of Screening and Early Intervention for Clinical High-Risk Psychosis
Cassetta, B. D., & Goghari, V. M. (2014) · Ethics & Behavior · doi:10.1080/10508422.2014.880920 · Cited by 15
Frydecka, D., Kotowicz, K., Gawęda, Ł., Prochwicz, K., Kłosowska, J., Rymaszewska, J., Samochowiec, A., Samochowiec, J., Podwalski, P., Pawlak, E., et al. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.103 · Cited by 14
Antipsychotics are related to psychometric conversion to psychosis in ultra‐high‐risk youth
Preti, A., Raballo, A., Meneghelli, A., Cocchi, A., Meliante, M., Barbera, S., Malvini, L., Monzani, E., & Percudani, M. (2021) · Early Intervention in Psychiatry · doi:10.1111/eip.13158 · Cited by 15
What is the Scientific Evidence for the Use of Antipsychotic Medication in Anorexia Nervosa?
Court, A., Mulder, C., Hetrick, S. E., Purcell, R., & McGorry, P. D. (2008) · Eating Disorders · doi:10.1080/10640260802016761 · Cited by 14
Outcome in patients converting to psychosis following a treated clinical high risk state
MALLA, A. K., de Bonneville, M., Shah, J. L., Jordan, G., Pruessner, M., Faridi, K., Rabinovitch, M., Iyer, S. N., & Joober, R. (2017) · Early Intervention in Psychiatry · doi:10.1111/eip.12431 · Cited by 14
Keefe, R. S. E., Woods, S. W., Cannon, T. D., Ruhrmann, S., Mathalon, D. H., McGuire, P. K., Rosenbrock, H., Daniels, K., Cotton, D., Roy, D., et al. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13083 · Cited by 14
Self-citationManaging the Prodrome of Schizophrenia
Fleischhacker, W. W., & Simma, A. M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_5 · Cited by 14
Roth, B. L. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.3/broth · Cited by 14
Psychose pour tous : la jeunesse au risque du« syndrome de psychose atténuée » ?
Évrard, R., & Rabeyron, T. (2014) · La psychiatrie de l enfant · doi:10.3917/psye.571.0331 · Cited by 13
Σκώκου, Μ., Katrivanou, A., Andriopoulos, I., & Gourzis, P. (2012) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2012.03.002 · Cited by 13
Antipsychotic treatments; focus on lurasidone
Sumiyoshi, T. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00102 · Cited by 13
Prediction and prevention of the first psychotic episode: new directions and opportunities
Marchese, G., Piras, S., Casu, G., Casu, M. A., Orrù, A., Ruiu, S., Pilleri, A., & Manca, G. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s55770 · Cited by 13
Tek, C., Küçükgöncü, S., Gülöksüz, S., Woods, S. W., Srihari, V. H., & Annamalai, A. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.140308 · Cited by 13
Self-citationAn Open-Label Study of Olanzapine in Children and Adolescents with Schizophrenia
Quintana, H., WILSON, M. S., Purnell, W., Layman, A. K., & Mercante, D. (2007) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000265765.25495.e0 · Cited by 13
Domínguez‐Martínez, T., Vainer, E., Massanet, M. A., Torices, I., Jané, M., & Barrantes‐Vidal, N. (2011) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 13
DSM‐5 and the ‘Psychosis Risk Syndrome’: Babylonic confusion
Kaymaz, N., & van Os, J. (2010) · Psychosis · doi:10.1080/17522431003753233 · Cited by 13
Zhang, T., Wang, J., Xu, L., Wei, Y., Tang, X., Hu, Y., Cui, H., Tang, Y., Hui, L., Li, C., et al. (2020) · Pharmacopsychiatry · doi:10.1055/a-1252-2942 · Cited by 13
Zhang, T., Xu, L., Wei, Y., Cui, H., Tang, X., Hu, Y., Tang, Y., Wang, Z., Liu, H., Chen, T., et al. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae066 · Cited by 12
Washida, K., Aoki, Habara, Sato, Oka, Takeda, Yosimura, & Tanaka (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s45697 · Cited by 12
Chen, C., Deng, Y., Li, Y., Zhang, M., Yu, T., Xie, K., Bao, W., Li, P., Sun, L., Zhang, T., et al. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae014 · Cited by 12
Applicability of the Chinese Version of the Prodromal Questionnaire
Chiu, S.-C., Hwu, H., Shiau, S., Yao, G., & Hsieh, Y. (2010) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(10)60105-2 · Cited by 12
Luutonen, S. H., Tikka, M., Karlsson, H., & Salokangas, R. K. R. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.005 · Cited by 12
Working With Asian American Youth at Clinical High Risk for Psychosis
Li, H., Friedman‐Yakoobian, M. S., Min, G., Gnong-Granato, A., & Seidman, L. J. (2013) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3182948084 · Cited by 12
Rethinking Risk in Pediatric Research
Glass, K. C., & Binik, A. (2008) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2008.305.x · Cited by 12
Preventing Schizophrenia and Severe Mental Illness
DeVylder, J. (2015) · Research on Social Work Practice · doi:10.1177/1049731515622687 · Cited by 15
Moukas, G., Stathopoulou, A., Gourzis, P., Beratis, I., & Beratis, S. (2009) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2009.02.001 · Cited by 12
Welsh, P., & Brown, S. R. (2013) · Health Risk & Society · doi:10.1080/13698575.2013.848846 · Cited by 12
Früherkennung und Frühbehandlung der Schizophrenie: Chance oder Dilemma?
Resch, F. (2008) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.36.4.235 · Cited by 12
EARLY DETECTION AND INTERVENTION FOR PSYCHOSIS: PERSPECTIVES FROM NORTH AMERICA.
Compton, M. T., Goulding, S. M., Ramsay, C. E., Addington, J., Corcoran, C. M., & Walker, E. F. (2008) · PubMed · Cited by 12
Self-citationGlutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia
Kantrowitz, J. T., & Javitt, D. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_3 · Cited by 12
Hardy, K. V., Moore, M., Rose, D., Bennett, R. W., Jackson-Lane, C., Gause, M., Jackson, A., & Loewy, R. L. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00310.x · Cited by 11
Hou, Y., Xia, H., He, T., Zhang, B., Qiu, G., & Chen, A. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20221013 · Cited by 11
The Next Big Thing in Child and Adolescent Psychiatry
Shoemaker, E. Z., Tully, L. M., Niendam, T. A., & Peterson, B. S. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.05.010 · Cited by 12
DSM‐5 and the ‘Psychosis Risk Syndrome’: Whose best interests would it serve?
Morrison, A. P., Byrne, R. E., & Bentall, R. P. (2010) · Psychosis · doi:10.1080/17522431003759982 · Cited by 11
Raballo, A., Poletti, M., & Preti, A. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab030 · Cited by 11
Kelly, C. J., Hadjinicolaou, A. V., Holt, C., Agius, M. A., & Zaman, R. (2010) · PubMed · Cited by 11
Ricci, V., Sarni, A., Martinotti, G., & Maina, G. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104725 · Cited by 10
IUPHAR review – Novel therapeutic targets for schizophrenia treatment: A translational perspective
Begni, V., Marchesin, A., & Riva, M. A. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107690 · Cited by 10
Law, H., Izon, E., Au‐Yeung, K., Morrison, A. P., Byrne, R. E., Notley, C. J., Yung, A. R., Norrie, J. D., & French, P. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12922 · Cited by 10
Baseline data of a sequential multiple assignment randomized trial (STEP study)
Hartmann, J., Nelson, B., Amminger, G. P., Spark, J., Yuen, H. P., Kerr, M., Polari, A. R., Wallis, N., Blasioli, J., Dixon, L. B., et al. (2022) · Early Intervention in Psychiatry · doi:10.1111/eip.13263 · Cited by 10
Overdiagnosis, Underdiagnosis, Synthesis: A Dialectic for Psychiatry and the DSM
Pierre, J. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6504-1_8 · Cited by 10
Treatment possibilities for individuals at clinical high risk of psychosis
Brummitt, K., & Addington, J. (2012) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2012.00370.x · Cited by 10
Self-citationActive and prodromal phase symptomatology of young-onset and late-onset paranoid schizophrenia
Σκώκου, Μ., Katrivanou, A., Andriopoulos, I., & Gourzis, P. (2012) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2012.03.002 · Cited by 10
Clinical Manual of Prevention in Mental Health
(2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378029 · Cited by 10
Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos, S., Kollias, C. T., Stefanis, N. C., & Kontaxakis, V. P. (2015) · PubMed · Cited by 10
Elwyn, R., Mitchell, J., Kohn, M. R., Driver, C., Hay, P., Lagopoulos, J., & Hermens, D. F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105122 · Cited by 10
Diagnosis and the staging model of psychosis
McGorry, P. D., Allott, K., & Jackson, H. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511576287.003 · Cited by 10
Treatment Delay in the Early Course of Schizophrenia and the Duration of Untreated Psychosis
Compton, M. T., Goulding, S. M., Broussard, B., & Trotman, H. D. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080801-03 · Cited by 10
Fear of annihilation in subjects at risk of psychosis: A pilot study
Davidsen, K., & Rosenbaum, B. (2012) · Psychosis · doi:10.1080/17522439.2011.588339 · Cited by 8
Stain, H. J., Clark, S. C., O׳Donnell, M., & Schall, U. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.493857 · Cited by 9
The Underlying Mechanisms for Olanzapine-induced Hypertriglyceridemia
Adachi (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr802w · Cited by 9
Psychological and social interventions for schizophrenia
Kingdon, D. (2006) · BMJ · doi:10.1136/bmj.333.7561.212 · Cited by 9
Yung, A. R. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.614926 · Cited by 9
Mees, L., Zdanowicz, N., Reynaert, C., & Jacques, D. (2011) · PubMed · Cited by 8
Ramella‐Cravaro, V., & Raballo, A. (2014) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 8
Moe, A. A. K., Scott, J. G., Burne, T. H. J., & Eyles, D. W. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116654776 · Cited by 8
Animal Models of Relevance to the Schizophrenia Prodrome
Petty, A. E., Howes, O. D., & Eyles, D. W. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.001 · Cited by 8
Prodromes de la schizophrénie : consensus ou confusion ?
Teyssier, J. (2013) · L Encéphale · doi:10.1016/j.encep.2012.11.002 · Cited by 8
Psychoedukation bei Personen mit erhöhtem Psychoserisiko
Zarafonitis, S., Wagner, M., Pützfeld, V., Berning, J., Janssen, B., Decker, P., Ronald Bottlender, A., Möller, H., Gäebel, W., Maier, W., et al. (2012) · Psychotherapeut · doi:10.1007/s00278-012-0928-6 · Cited by 8
Lim, K., Lee, T. Y., Kim, M., Chon, M., Yun, J., Kim, S. N., & Kwon, J. S. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12363 · Cited by 8
Schizopsychotic symptom-profiles and biomarkers: Beacons in diagnostic labyrinths
Palomo, T., Kostrzewa, R. M., Beninger, R. J., & Archer, T. (2008) · Neurotoxicity Research · doi:10.1007/bf03033800 · Cited by 8
ECONOMIC IMPACT OF EARLY INTERVENTION IN PEOPLE AT HIGH RISK OF PSYCHOSIS
Valmaggia, L., McCrone, P., Knapp, M. R. J., Broome, M. R., Power, P., & McGuire, P. K. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.484 · Cited by 8
Block, J. J. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1838 · Cited by 8
Edemann-Callesen, H., Winter, C., & Hadar, R. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.03.018 · Cited by 8
A prevalência da depressão pós-parto e suas consequências em mulheres no Brasil
de Souza, N. K. P., de Magalhães, E. Q., & Rodrigues, O. M. (2021) · Research Society and Development · doi:10.33448/rsd-v10i15.23272 · Cited by 7
Attitudes of patients and clinicians in relation to the at‐risk state for psychosis
Welsh, P., & Tiffin, P. A. (2013) · Early Intervention in Psychiatry · doi:10.1111/eip.12062 · Cited by 7
Training service-providers regarding youth at risk for psychosis
Golembo-Smith, S., Denenny, D. M., Kishimoto, E., & Schiffman, J. E. (2011) · Asia-Pacific Psychiatry · doi:10.1111/j.1758-5872.2011.00110.x · Cited by 7
Is clinical intervention in the ultra high risk phase effective?
McGuire, P. K., Selvaraj, S., & Howes, O. D. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000600004 · Cited by 7
Cognitive‐behavioral therapy for individuals at high risk of developing psychosis
Addington, J., & Mancuso, E. (2009) · Journal of Clinical Psychology · doi:10.1002/jclp.20609 · Cited by 7
Self-citationHealth literacy in clinical‐high‐risk individuals for psychosis: A systematic mixed‐methods review
Haidl, T. K., Seves, M., Eggers, S., Rostamzadeh, A., Genske, A., Jünger, S., Woopen, C., Jessen, F., Ruhrmann, S., & Vogeley, K. T. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12776 · Cited by 7
Does early diagnosis and treatment of schizophrenia lead to improved long-term outcomes?
Agius, M. A., Butler, S., & Holt, C. (2011) · Neuropsychiatry · doi:10.2217/npy.11.71 · Cited by 7
Clinical Staging in Schizophrenia Spectrum Disorders
Dombi, Z. B., Barabássy, Á., Sebe, B., Laszlovszky, I., & Németh, G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98276 · Cited by 6
Early Interventions in High Risk Groups for Psychotic Disorders
Erzın, G., & Gülöksüz, S. (2021) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27404 · Cited by 6
Wang, P., Yan, C.-D., Dong, X.-J., Geng, L., Xu, C., Nie, Y., & Zhang, S. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i8.2420 · Cited by 6
Castle, D. J., Copolov, D., SINGH, B. S., & Bastiampillai, T. J. (2023) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674231209840 · Cited by 6
Robbins, B. D., Higgins, M., Fisher, M., & Over, K. (2011) · Journal of Psychological Issues in Organizational Culture · doi:10.1002/jpoc.20039 · Cited by 6
Effects of Appraisals of Anomalous Experience on Distress in People at Risk of Psychosis
Taylor, H. E., Parker, S., Mansell, W., & Morrison, A. P. (2012) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465812000227 · Cited by 6
Abubaker, R., Alaerts, M., Allman, A.-A., Barnett, J. H., Belujon, P., Bittner, R. A., Burne, T. H. J., Cahn, W., Chance, S. A., Cherkerzian, S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.015 · Cited by 6
Duffy, F. H., D’Angelo, E. J., Rotenberg, A., & Gonzalez–Heydrich, J. (2015) · BMC Medicine · doi:10.1186/s12916-015-0516-z · Cited by 6
The early identification of psychosis: can lessons be learnt from cardiac stress testing?
Gupta, S., Ranganathan, M., & D’Souza, D. C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4143-3 · Cited by 6
Cadenhead, K. S., & Mirzakhanian, H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060789 · Cited by 6
First-episode psychosis: An update
Chiliza, B., Oosthuizen, P. P., & Emsley, R. A. (2008) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v14i1.83 · Cited by 6
Research in young people at ultra-high risk for psychosis: a review of the current evidence
O’Connor, K. (2013) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2012.9 · Cited by 6
Pharmacological Treatment of Schizophrenia:
Fleischhacker, W. W., & Miyamoto, S. (2016) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.7.1 · Cited by 6
Early Intervention for Better Mental Health Services
Rosen, A., Byrne, P., Goldstone, S. D., & McGorry, P. D. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch99 · Cited by 6
Prediction and Early Detection of First-Episode Psychosis
Schultze‐Lutter, F., Michel, C., Ruhrmann, S., Klosterkötter, J., & SCHIMMELMANN, B. G. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0_9 · Cited by 5
Impact of early social isolation on social circuits and behavior: relevance to schizophrenia
Kawatake-Kuno, A., Leventhal, M. B., & Morishita, H. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02156-6 · Cited by 7
Multimodal functional imaging investigation before and after the onset of psychosis
Fusar‐Poli, P., Howes, O. D., Valli, I., Allen, P., Broome, M. R., Grasby, P. M., & McGuire, P. K. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570800953x · Cited by 5
Metadata
- Authors
- McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., A. Hawkins, K., E. Hoffman, R., Preda, A., Epstein, I., Addington, D., Lindborg, S., Trzaskoma, Q., Tohen, M., & Breier, A.
- Affiliations
- Yale University (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2006-05
- Volume
- 163
- Issue
- 5
- Pages
- 790-799
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2121366540
- Cited by
- 556
- References
- 30
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 12 · 2023: 7 · 2022: 6 · 2021: 18 · 2020: 21 · 2019: 18 · 2018: 10 · 2017: 12 · 2016: 31 · 2015: 26 · 2014: 28 · 2013: 38 · 2012: 47
- FWCI
- 32.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- Funders
- Eli Lilly and Company
- University of Toronto
- National Institutes of Health (5r24mh054446-05)
- National Institute of Mental Health (K05 MH-01654, MH01654, 1 K23 MH01905, K23MH001905, R01MH067073, R01 MH-67073, R24-MH-54446, R02 MH-50557, K05MH001654)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- olanzapine, transition to psychosis, weight gain, atypical antipsychotics
- MeSH terms
- Olanzapine, Adolescent, Ambulatory Care, Benzodiazepines, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Obesity, Placebos, Psychiatric Status Rating Scales, Schizophrenia, Schizophrenic Psychology, Severity of Illness Index, Antipsychotic Agents, Weight Gain, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
